Suppr超能文献

血液病患者产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌血症的监测培养的预测价值。

Predictive value of surveillance cultures for bacteremia caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales among patients with hematological diseases.

机构信息

Department of Clinical Laboratory, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.

Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.

出版信息

Infection. 2022 Jun;50(3):753-759. doi: 10.1007/s15010-021-01753-z. Epub 2022 Jan 10.

Abstract

PURPOSE

Due to the increasing prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, empirical therapies with cefepime or piperacillin/tazobactam for hematology patients with febrile neutropenia have become ineffective. Carbapenems should be administered as soon as possible in such patients with ESBL bacteremia. If the surveillance culture results are consistent with the blood culture findings, the time to adequate treatment initiation can be shortened.

METHODS

All consecutive patients with Enterobacterales bacteraemia who were admitted from January 2013 to December 2018 at the hematology wards were enrolled in this study. Surveillance rectal swab and blood culture results were compared.

RESULTS

In total, 67 patients with Enterobacterales bacteremia underwent surveillance culture prior to the onset of infection. Regarding the presence or absence of ESBL-producing Enterobacterales, 64 (95.5%) patients had surveillance results concordant with blood culture results. The positive predictive value of surveillance culture for bacteremia caused by ESBL-producing Enterobacterales was 95.0%. Moreover, the negative predictive value of surveillance culture for bacteremia caused by non-ESBL-producing Enterobacterales was 95.7%.

CONCLUSION

The concordance rate between the surveillance rectal swab and blood cultures was highly acceptable. Surveillance rectal swab cultures are useful for identifying patients at high risk for ESBL bacteremia.

摘要

目的

由于产Extended-spectrum beta-lactamase (ESBL)的肠杆菌科细菌的发病率不断增加,对于患有发热性中性粒细胞减少症的血液科患者,经验性使用头孢吡肟或哌拉西林/他唑巴坦治疗已不再有效。此类产 ESBL 菌血症患者应尽快给予碳青霉烯类药物治疗。如果监测培养结果与血培养结果一致,则可缩短开始充分治疗的时间。

方法

本研究纳入了 2013 年 1 月至 2018 年 12 月期间在血液科病房住院的所有连续发生肠杆菌科血流感染的患者。比较了监测直肠拭子和血培养的结果。

结果

共有 67 例肠杆菌科血流感染患者在感染前进行了监测培养。关于产 ESBL 或不产 ESBL 肠杆菌科细菌的存在情况,64 例(95.5%)患者的监测结果与血培养结果一致。监测直肠拭子培养对产 ESBL 肠杆菌科细菌引起的菌血症的阳性预测值为 95.0%。此外,监测直肠拭子培养对非产 ESBL 肠杆菌科细菌引起的菌血症的阴性预测值为 95.7%。

结论

监测直肠拭子与血培养的一致性非常高。监测直肠拭子培养有助于识别发生产 ESBL 菌血症的高危患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验